GPCRs promote the release of zinc ions mediated by nNOS/NO and the redox transducer RGSZ2 protein

Antioxidants and Redox Signaling

Volumn 17, Issue 9, 2012, Pages 1163-1177

  Sánchez Blázquez, Pilar ^a   Rodríguez Muñoz, María ^a   Bailón, Concha ^a   Garzón, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANANDAMIDE; BIOGENIC AMINE; CANNABINOID 1 RECEPTOR; DELTA OPIATE RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; MU OPIATE RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPEPTIDE; NITRIC OXIDE; PROTEIN; PROTEIN KINASE C GAMMA; RAF PROTEIN; RGSZ2 PROTEIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; ZINC ION;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ZINC FINGER MOTIF; ZINC METABOLISM;

ANIMALS; IMMUNOPRECIPITATION; MICE; NITRIC OXIDE SYNTHASE TYPE I; NITROGEN OXIDES; OXIDATION-REDUCTION; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; RGS PROTEINS; ZINC;

EID: 84865618971     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4517     Document Type: Article

References (50)

1. Ajit SK, Ramineni S, Edris W, Hunt RA, Hum WT, Hepler JR, and Young KH. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling. Cell Signal 19:723-730, 2007. (Pubitemid 46275365)
2. Barbier E and Wang JB. Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci 10:132, 2009.
3. Bokoch GM, Diebold B, Kim JS, and Gianni D. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal 11:2429-2441, 2009.
4. Colvin RA, Holmes WR, Fontaine CP, and Maret W. Cytosolic zinc buffering and muffling: Their role in intracellular zinc homeostasis. Metallomics 2:306-317, 2010.
5. Cope EC and Levenson CW. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care 13:685-689, 2010.
6. Csermely P, Szamel M, Resch K, and Somogyi J. Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J Biol Chem 263:6487-6490, 1988.
7. Csermely P, Szamel M, Resch K, and Somogyi J. Zinc increases the affinity of phorbol ester receptor in T lymphocytes. Biochem Biophys Res Commun 154:578-583, 1988.
8. Doyle T, Bryant L, Muscoli C, Cuzzocrea S, Esposito E, Chen Z, and Salvemini D. Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci Lett 483:85-89, 2010.
9. Garcia DE, Brown S, Hille B, and Mackie K. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18:2834-2841, 1998. (Pubitemid 28163213)
10. Garzón J, De la Torre-Madrid E, Rodríguez-Muñoz M, Vicente-Sánchez A, and Sánchez-Blázquez P. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Molecular Pain 5:11, 2009.
11. Garzón J, Rodríguez-Muñoz M, López-Fando A, and Sánchez-Blázquez P. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins. Neuropsychopharmacology 30:1632-1648, 2005. (Pubitemid 43086021)
12. Garzón J, Rodríguez-Muñoz M, and Sánchez- Blázquez P. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter. Neuropharmacology 48:853-868, 2005. (Pubitemid 40489041)
13. Garzón J, Rodriguez-Muñoz M, and Sánchez- Blázquez P. Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr Drug Abuse Rev 1:222-238, 2008.
14. Garzón J, Rodríguez-Muñoz M, Vicente-Sánchez A, Bailón C, Martínez-Murillo R, and Sánchez- Blázquez P. RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the Nmethyl-D-aspartate receptor-calmodulin-dependent protein kinase II pathway. Antioxid Redox Signal 15:873-887, 2011.
15. Garzón J, Rodríguez-Muñoz M, Vicente-Sánchez A, García-López MA, Martínez-Murillo R, Fischer T, and Sánchez-Blázquez P. SUMO-SIM interactions regulate the activity of RGSZ2 proteins. PLoS One 6:e28557, 2011.
16. Grabrucker AM, Rowan M, and Garner CC. Brain-delivery of zinc-ions as potential treatment for neurological diseases: Mini review. Drug Deliv Lett 1:13-23, 2011.
17. Grabrucker AM, Schmeisser MJ, Udvardi PT, Arons M, Schoen M, Woodling NS, Andreasson KI, Hof PR, Buxbaum JD, Garner CC, and Boeckers TM. Amyloid beta proteininduced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold. Mol Neurodegener 6:65, 2011.
18. Guang W, Wang H, Su T, Weinstein IB, and Wang JB. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphineinduced analgesia. Mol Pharmacol 66:1285-1292, 2004. (Pubitemid 39411068)
19. Hoyos B, Imam A, Chua R, Swenson C, Tong GX, Levi E, Noy N, and Hammerling U. The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J Exp Med 192:835-845, 2000.
20. Ilbert M, Graf PC, and Jakob U. Zinc center as redox switch-New function for an old motif. Antioxid Redox Signal 8:835-846, 2006. (Pubitemid 44036501)
21. Jordan JD, Carey KD, Stork PJ, and Iyengar R. Modulation of rap activity by direct interaction of Galpha (o) with Rap1 GTPase-activating protein. J Biol Chem 274:21507-21510, 1999.
22. Knapp LT and Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem 275:24136-24145, 2000. (Pubitemid 30624705)
23. Korichneva I. Zinc dynamics in the myocardial redox signaling network. Antioxid Redox Signal 8:1707-1721, 2006. (Pubitemid 44726343)
24. Korichneva I, Hoyos B, Chua R, Levi E, and Hammerling U. Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen. J Biol Chem 277:44327-44331, 2002. (Pubitemid 36157867)
25. Lima CD, Klein MG, Weinstein IB, and Hendrickson WA. Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci USA 93:5357-5362, 1996. (Pubitemid 26159454)
26. Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, Sherrington R, Adolfsson R, and Jazin E. A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am J Hum Genet 69:96-105, 2001. (Pubitemid 32614022)
27. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov 5:160-170, 2006.
28. Liu Q, Puche AC, and Wang JB. Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem Res 33:1263-1276, 2008.
29. Maeng S and Zarate Jr CA. The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9:467-474, 2007. (Pubitemid 350284937)
30. Mao H, Zhao Q, Daigle M, Ghahremani MH, Chidiac P, and Albert PR. RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling. J Biol Chem 279:26314-26322, 2004.
31. Maret W. The function of zinc metallothionein: A link between cellular zinc and redox state. J Nutr 130:1455S-1458S, 2000. (Pubitemid 30244145)
32. Maret W. Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid Redox Signal 8:1419-1441, 2006. (Pubitemid 44726320)
33. Maret W and Vallee BL. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA 95:3478-3482, 1998. (Pubitemid 28173153)
34. Marino SM and Gladyshev VN. Redox biology: Computational approaches to the investigation of functional cysteine residues. Antioxid Redox Signal 15:135-146, 2011.
35. McDonald JR, Groschel-Stewart U, and Walsh MP. Properties and distribution of the protein inhibitor (Mr 17, 000) of protein kinase C. Biochem J 242:695-705, 1987. (Pubitemid 17049488)
36. Mechri A, Saoud M, Khiari G, D'Amato T, Dalery J, and Gaha L. Glutaminergic hypothesis of schizophrenia: Clinical research studies with ketamine. Encephale 27:53-59, 2001. (Pubitemid 32234479)
37. Mocchegiani E, Bertoni-Freddari C, Marcellini F, and Malavolta M. Brain, aging and neurodegeneration: Role of zinc ion availability. Prog Neurobiol 75:367-390, 2005. (Pubitemid 40827125)
38. Nowak G, Szewczyk B, and Pilc A. Zinc and depression. An update. Pharmacol Rep 57:713-718, 2005.
39. Palumaa P. Biological redox switches. Antioxid Redox Signal 11:981-983, 2009.
40. Parker PJ, Coussens L, Totty N, Rhee L, Young S, Chen E, Stabel S, Waterfield MD, and Ullrich A. The complete primary structure of protein kinase C-The major phorbol ester receptor. Science 233:853-859, 1986. (Pubitemid 16011893)
41. Patel HH and Insel PA. Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid Redox Signal 11:1357-1372, 2009.
42. Rodríguez-Muñoz M, De la Torre-Madrid E, Sánchez-Blázquez P, and Garzón J. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins. Mol Pain 3:19, 2007.
43. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Bailón C, Martín-Aznar B, and Garzón J. The histidine triad nucleotide-binding protein 1 supports mu-opioid receptorglutamate NMDA receptor cross-regulation. Cell Mol Life Sci 68:2933-2949, 2011.
44. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Berrocoso E, and Garzón J. The mu-opioid receptor and the NMDA receptor associate in PAG neurons: Implications in pain control. Neuropsychopharmacology 37:338-349, 2012.
45. Rodríguez-Muñoz M, Torre-Madrid E, Sánchez- Blázquez P, and Garzón J. NO-released zinc supports the simultaneous binding of Raf-1 and PKCgamma cysteine-rich domains to HINT1 protein at the mu-opioid receptor. Antioxid Redox Signal 14:2413-2425, 2011.
46. Rodríguez-Muñoz M, Torre-Madrid E, Sánchez- Blázquez P, Wang JB, and Garzón J. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors. Cell Signal 20:1855-1864, 2008.
47. Sánchez-Blázquez P, Rodríguez-Muñoz M, and Garzón J. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5:e11278, 2010.
48. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de LP, DasGupta BR, and Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832-835, 1992.
49. Shahani N and Sawa A. Nitric oxide signaling and nitrosative stress in neurons: Role for S-nitrosylation. Antioxid Redox Signal 14:1493-1504, 2011.
50. Zhao F, Ilbert M, Varadan R, Cremers CM, Hoyos B, Acin-Perez R, Vinogradov V, Cowburn D, Jakob U, and Hammerling U. Are zinc-finger domains of protein kinase C dynamic structures that unfold by lipid or redox activation? Antioxid Redox Signal 14:757-766, 2011.